Skip to search formSkip to main contentSkip to account menu

SK-OV-3

An adenocarcinoma cell line established from the ascetic fluid of a 64 year old Caucasian female patient with ovarian carcinoma previously treated… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Leukotriene B4 receptor-2 contributes to chemoresistance of SK-OV-3 ovarian cancer cells through activation of signal transducer and activator of transcription-3-linked cascade.
2015
2015
Abstract 666: Activity of the MEK inhibitor Binimetinib (MEK162) in combination with paclitaxel in patient-derived xenograft models of high-grade serous ovarian carcinoma
High-grade serous ovarian carcinoma (HGSOC) has the poorest prognosis amongst all gynecological cancers with a median survival of… 
2014
2014
Abstract 3806: STAT3/STAT5 blockade by WP1066 inhibits ovarian cancer cell proliferation and induces cell death
Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA BACKGROUND: Ovarian cancer is the most deadly gynecologic… 
2005
2005
11,11′-Dideoxy-verticillin: a natural compound possessing growth factor receptor tyrosine kinase-inhibitory effect with anti-tumor activity
11,11′-Dideoxy-verticillin, a compound of the novel epidithiodioxopiprazine structural class, is isolated from the traditional… 
2001
2001
Regulation of Complement Classical Pathway by Association of C4b-Binding Protein to the Surfaces of SK-OV-3 and Caov-3 Ovarian Adenocarcinoma Cells1
The role of fluid-phase regulators of complement is to inhibit excessive complement activation and maintain homeostasis in blood… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)